(b)
Partial response | Stable disease | Progressive disease | |
---|---|---|---|
DAC | Malignant pleural tumor | Colorectal adenocarcinoma Esophageal adenocarcinoma |
Alveolar carcinoma Intrahepatic bile ducts adenocarcinoma Hepatocellular carcinoma Gastric cancer |
| |||
DAC + chemo | Ovary carcinoma Lung adenocarcinoma |
Tubal serous adenocarcinoma Lung adenocarcinoma Cardia adenocarcinoma Hodgkin's lymphoma Non-Hodgkin's lymphoma |
Cervical squamous cell carcinomas Lung adenocarcinoma Small cell carcinoma of the esophagus Esophageal squamous cell carcinomas Colon adenocarcinoma Non-Hodgkin's lymphoma |
| |||
DAC + CIK | — | Pancreatic cancer Hepatocellular carcinoma |
Hepatocellular carcinoma |
Note. CIK: cytokine induced killer cells; DAC + chemo: decitabine in combination with chemotherapy; DAC + CIK: decitabine in combination with CIK.